By Josh White
Date: Tuesday 04 Nov 2025
(Sharecast News) - RUA Life Sciences reported a sharp increase in revenue for the 18 months ended 30 September on Tuesday, reflecting its successful transition from a research-led organisation to a revenue-generating medical device group.
| Cancellation & Reissue Share Options | 10-Dec-2025 | 14:55 | RNS |
| Trading update | 04-Nov-2025 | 07:00 | RNS |
| 12 Month Interim Results | 25-Jun-2025 | 07:00 | RNS |
| Director/PDMR Shareholding | 06-May-2025 | 09:30 | RNS |
| Change of Registered Office | 30-Apr-2025 | 11:45 | RNS |
| Stalemate in legal dispute at AorTech | 30-Sep-2014 | The Herald |
| AIM hopes help Aortech to soar | 25-Nov-2011 | The Herald |
| AorTech surges on supply agreement | 19-May-2009 | The Herald |
| Director Dealings: Archial proves attractive | 13-Apr-2009 | Scotland on Sunday |
| AorTech founders sell shares to board | 07-Apr-2009 | The Herald |
| AorTech leads gainers on latest Scottish StockWa... | 04-Nov-2006 | The Scotsman |
| Smaller stock to watch | 26-Oct-2006 | Times |
| Reeling Plusnet at two-year low as broadband bat... | 08-Aug-2006 | Times |
| Vodafone is ringing a few alarm bells | 21-Jan-2006 | The Scotsman |
| Tomb Raider company takes a hit | 21-Jan-2006 | Guardian |
No recent information was found.
| Currency | UK Pounds |
| Share Price | 13.75p |
| Change Today | -0.25p |
| % Change | -1.79 % |
| 52 Week High | 14.31 |
| 52 Week Low | 10.50 |
| Volume | 349,609 |
| Shares Issued | 62.06m |
| Market Cap | £8.53m |
| Beta | 0.10 |
| RiskGrade | 290 |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income | ![]() |
|---|
| Growth |
|
|---|
| No dividends found |
| Time | Volume / Share Price |
| 16:24 | 10,000 @ 13.25p |
| 11:49 | 15,000 @ 13.60p |
| 11:44 | 25,000 @ 13.65p |
| 11:23 | 6,010 @ 14.11p |
| 10:13 | 50,000 @ 13.82p |
| CEO | William D Brown |
| CFO | Lachlan Smith |
You are here: research